MS4A13

gene
On this page

Summary

MS4A13 (membrane spanning 4-domains A13, HGNC:16674) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 13 (Q5J8X5). May be involved in signal transduction as a component of a multimeric receptor complex.

Predicted to be involved in cell surface receptor signaling pathway. Predicted to be located in membrane. Predicted to be active in plasma membrane.

Source: NCBI Gene 503497 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 24 total
  • MANE Select transcript: NM_001012417

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16674
Approved symbolMS4A13
Namemembrane spanning 4-domains A13
Location11q12.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000204979
Ensembl biotypeprotein_coding
Entrez503497

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000378185, ENST00000378186, ENST00000437058, ENST00000527948

RefSeq mRNA: 3 — MANE Select: NM_001012417 NM_001012417, NM_001100909, NM_001278320

CCDS: CCDS31571, CCDS41653, CCDS60801

Canonical transcript exons

ENST00000378186 — 7 exons

ExonStartEnd
ENSE000014765886054251960542721
ENSE000014765896052936560529460
ENSE000014765926052520760525326
ENSE000014765946052389760523953
ENSE000014765956051807260518212
ENSE000014765966051596960516084
ENSE000038900146051539260515607

Expression profiles

Bgee: expression breadth tissue_specific, 10 present calls, max score 82.18.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0076 / max 2.9335, expressed in 4 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1144790.00764

Top tissues by expression

128 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.18gold quality
testisUBERON:000047362.57gold quality
left testisUBERON:000453362.49gold quality
right testisUBERON:000453461.92gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099160.27gold quality
bone marrow cellCL:000209239.22gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
bone marrowUBERON:000237133.30gold quality
muscle tissueUBERON:000238532.50gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
sural nerveUBERON:001548830.93gold quality
stromal cell of endometriumCL:000225529.87gold quality
monocyteCL:000057629.86silver quality
leukocyteCL:000073829.65silver quality
prefrontal cortexUBERON:000045129.26gold quality
liverUBERON:000210728.34gold quality
duodenumUBERON:000211428.14gold quality
lymph nodeUBERON:000002927.57gold quality
tonsilUBERON:000237227.05gold quality
bloodUBERON:000017826.65gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
gall bladderUBERON:000211025.98gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
adrenal tissueUBERON:001830325.76gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.76

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

20 targeting MS4A13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-50799.9770.111915
HSA-MIR-55799.9670.011640
HSA-MIR-545-3P99.9570.742783
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-4756-3P99.6266.301319
HSA-MIR-3120-3P99.5470.282669
HSA-MIR-5571-5P99.4966.991764
HSA-MIR-478499.1567.411733
HSA-MIR-3150B-3P98.8167.211728
HSA-MIR-468996.9765.791209
HSA-MIR-6858-5P96.0564.591020

Cross-species orthologs

26 orthologs

OrganismSymbolGene ID
danio_rerioms4a17a.6ENSDARG00000007018
danio_rerioms4a17a.4ENSDARG00000014024
danio_reriosi:dkey-77f5.10ENSDARG00000020548
danio_reriozgc:113425ENSDARG00000026616
danio_rerioms4a17c.2ENSDARG00000028659
danio_rerioms4a17a.7ENSDARG00000043796
danio_rerioms4a17a.1ENSDARG00000043798
danio_rerioms4a17a.8ENSDARG00000043802
danio_rerioms4a17a.12ENSDARG00000053563
danio_rerioms4a17a.16ENSDARG00000054898
danio_reriosi:dkey-7j14.6ENSDARG00000090552
danio_rerioms4a17a.3ENSDARG00000091970
danio_rerioms4a17a.5ENSDARG00000092204
danio_reriosi:dkey-174k12.3ENSDARG00000092593
danio_reriosi:dkey-238j22.1ENSDARG00000093512
danio_reriosi:ch73-56d11.5ENSDARG00000093546
danio_rerioms4a17c.1ENSDARG00000094643
danio_rerioms4a17a.11ENSDARG00000094809
danio_rerioms4a17a.9ENSDARG00000094854
danio_rerioms4a17a.10ENSDARG00000095695
danio_reriosi:ch73-56d11.3ENSDARG00000097527
danio_reriotmem176l.3aENSDARG00000098387
danio_rerioms4a17a.2ENSDARG00000105674
danio_rerioms4a17a.17ENSDARG00000116378
mus_musculusMs4a13ENSMUSG00000057240
rattus_norvegicusMs4a13ENSRNOG00000033714

Paralogs (16): MS4A12 (ENSG00000071203), MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)

Protein

Protein identifiers

Membrane-spanning 4-domains subfamily A member 13Q5J8X5 (reviewed: Q5J8X5)

Alternative names: Testis-expressed transmembrane protein 4

All UniProt accessions (2): Q5J8X5, E9PPG1

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in signal transduction as a component of a multimeric receptor complex.

Subcellular location. Membrane.

Similarity. Belongs to the MS4A family.

Isoforms (3)

UniProt IDNamesCanonical?
Q5J8X5-11yes
Q5J8X5-22
Q5J8X5-33

RefSeq proteins (3): NP_001012417, NP_001094379, NP_001265249 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007237CD20-like_TMDomain
IPR030417MS4AFamily

Pfam: PF04103

UniProt features (11 total): transmembrane region 4, sequence variant 3, splice variant 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5J8X5-F186.390.48

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 17 (showing top): GTGCAAA_MIR507, MIR545_3P, MIR1185_1_3P_MIR1185_2_3P, LET_7F_2_3P, MIR507, MIR557, MIR4784, MIR3150B_3P, GSE13306_TREG_VS_TCONV_UP, GSE13306_RA_VS_UNTREATED_TCONV_UP, GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP, GSE28237_EARLY_VS_LATE_GC_BCELL_UP, chr11q12, GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN, GSE31622_WT_VS_KLF3_KO_BCELL_DN

GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
signal transduction1
binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

62 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MS4A13TMEM185BQ9H7F4375
MS4A13SH3TC1Q8TE82370
MS4A13FAM110CQ1W6H9370
MS4A13MAMDC4Q6UXC1348
MS4A13PLSCR2Q9NRY7336
MS4A13LRRC47Q8N1G4325
MS4A13DCDC1P59894290
MS4A13OPN5Q6U736266
MS4A13PCDHA7Q9UN72263
MS4A13FSIP2Q5CZC0260
MS4A13SPAG17Q6Q759252
MS4A13ODAMA1E959248
MS4A13NEUROD4Q9HD90246
MS4A13TACC2O95359227
MS4A13CCDC40Q4G0X9223

IntAct

187 interactions, top by confidence:

ABTypeScore
MS4A13SLC30A2psi-mi:“MI:0915”(physical association)0.600
MS4A13GJA8psi-mi:“MI:0915”(physical association)0.560
MS4A13TMC4psi-mi:“MI:0915”(physical association)0.560
MS4A13LRRC3Bpsi-mi:“MI:0915”(physical association)0.560
MS4A13SLC7A1psi-mi:“MI:0915”(physical association)0.560
MS4A13SCN3Bpsi-mi:“MI:0915”(physical association)0.560
MS4A13EREGpsi-mi:“MI:0915”(physical association)0.560
MS4A13RAMP1psi-mi:“MI:0915”(physical association)0.560
MS4A13GJA5psi-mi:“MI:0915”(physical association)0.560
MS4A13RNF185psi-mi:“MI:0915”(physical association)0.560
MS4A13EDApsi-mi:“MI:0915”(physical association)0.560
MS4A13CREB3L3psi-mi:“MI:0915”(physical association)0.560
MS4A13CREB3L1psi-mi:“MI:0915”(physical association)0.560
MS4A13SLC12A7psi-mi:“MI:0915”(physical association)0.560
MS4A13SPAG4psi-mi:“MI:0915”(physical association)0.560
KLRC1MS4A13psi-mi:“MI:0915”(physical association)0.560
MS4A13HERPUD2psi-mi:“MI:0915”(physical association)0.560
MS4A13SLC13A4psi-mi:“MI:0915”(physical association)0.560
MS4A13psi-mi:“MI:0915”(physical association)0.560
MS4A13MS4A3psi-mi:“MI:0915”(physical association)0.560
MS4A13JSRP1psi-mi:“MI:0915”(physical association)0.560
ASGR2MS4A13psi-mi:“MI:0915”(physical association)0.560
MS4A13TMEM237psi-mi:“MI:0915”(physical association)0.560
BIKMS4A13psi-mi:“MI:0915”(physical association)0.560
MS4A13POMKpsi-mi:“MI:0915”(physical association)0.560

BioGRID (63): MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid), MS4A13 (Two-hybrid)

ESM2 similar proteins: A0A2R8RY99, A4IIV4, A8MUP6, A9UL59, B2RVW2, C9JDP6, E9Q6I0, H7C241, O95859, P0DP42, P56749, Q0IIL2, Q0V9E0, Q29RH7, Q2KHT4, Q32KQ5, Q3SZT1, Q3T110, Q3UUA0, Q4V922, Q5CZV0, Q5FWC3, Q5J8X5, Q5R8B5, Q5R9K1, Q6AXT9, Q6AYL2, Q6GV27, Q6GV28, Q6ICI0, Q7T392, Q80SV1, Q80WE5, Q86WI0, Q8CJ58, Q8K445, Q8NHS1, Q8R1W2, Q8VI88, Q96CE8

Diamond homologs: Q2YDM3, Q5FWC3, Q5J8X5, Q99N10

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 60 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Gap junction assembly646.2×4e-07

GO biological processes:

GO termPartnersFoldFDR
cell-cell signaling810.7×3e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

24 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance17
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1116 predictions. Top by Δscore:

VariantEffectΔscore
11:60515596:G:GGdonor_gain1.0000
11:60518190:G:GTdonor_gain1.0000
11:60515608:G:Tdonor_gain0.9900
11:60516082:GGG:Gdonor_gain0.9900
11:60516083:GGG:Gdonor_gain0.9900
11:60518690:G:GTdonor_gain0.9900
11:60515606:GG:Gdonor_gain0.9800
11:60515607:GG:Gdonor_gain0.9800
11:60515702:AAAC:Adonor_gain0.9800
11:60515703:AACA:Adonor_gain0.9800
11:60515707:G:GGdonor_gain0.9800
11:60518070:A:AGacceptor_gain0.9800
11:60518071:G:GGacceptor_gain0.9800
11:60518112:G:GAdonor_gain0.9800
11:60518189:GGAT:Gdonor_gain0.9800
11:60518213:G:GGdonor_gain0.9800
11:60525324:GCA:Gdonor_gain0.9800
11:60518208:TTTTT:Tdonor_gain0.9700
11:60525327:G:GGdonor_gain0.9700
11:60515657:G:Tdonor_gain0.9600
11:60515663:G:GTdonor_gain0.9600
11:60542517:A:AGacceptor_gain0.9600
11:60542518:G:GGacceptor_gain0.9600
11:60516083:GG:Gdonor_gain0.9500
11:60516084:GG:Gdonor_gain0.9500
11:60518178:C:Gdonor_gain0.9500
11:60516081:AGGG:Adonor_loss0.9400
11:60516082:GGGG:Gdonor_loss0.9400
11:60516083:GGGT:Gdonor_loss0.9400
11:60516085:GT:Gdonor_loss0.9400

AlphaMissense

978 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:60518111:T:AW10R0.993
11:60518111:T:CW10R0.993
11:60518201:T:AW40R0.992
11:60518201:T:CW40R0.992
11:60518156:T:CF25L0.991
11:60518158:T:AF25L0.991
11:60518158:T:GF25L0.991
11:60529371:G:AG105R0.991
11:60529371:G:CG105R0.991
11:60529371:G:TG105W0.991
11:60518204:G:AG41R0.990
11:60518204:G:CG41R0.990
11:60529376:G:CR106S0.990
11:60529376:G:TR106S0.990
11:60525280:A:TE87V0.989
11:60518090:G:CG3R0.988
11:60525258:G:CA80P0.986
11:60525291:T:CF91L0.985
11:60525293:T:AF91L0.985
11:60525293:T:GF91L0.985
11:60518172:C:AP30H0.984
11:60529372:G:AG105E0.984
11:60525259:C:AA80E0.982
11:60529372:G:TG105V0.982
11:60525279:G:AE87K0.981
11:60525314:T:AN98K0.981
11:60525314:T:GN98K0.981
11:60525237:T:CC73R0.980
11:60525280:A:CE87A0.980
11:60525324:G:CA102P0.977

dbSNP variants (sampled 300 via entrez): RS1000027153 (11:60521365 T>C), RS1000102863 (11:60532256 G>A,T), RS1000142860 (11:60521596 A>G), RS1000172393 (11:60538871 G>C,T), RS1000492725 (11:60513891 T>C,G), RS1000525222 (11:60525418 C>A,G,T), RS1000630693 (11:60531248 G>T), RS1000718817 (11:60540749 C>T), RS1000745038 (11:60531424 A>G), RS1001032381 (11:60519665 A>G), RS1001043079 (11:60525788 C>G,T), RS1001146755 (11:60520043 A>G), RS1001225320 (11:60530925 TC>T), RS1001356028 (11:60526637 T>A,C), RS1001438489 (11:60518437 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST002119_24Metabolite levels (X-11787)4.000000e-06
GCST004721_17Congenital heart disease (maternal effect)4.000000e-07
GCST005231_55Major depressive disorder4.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005276hydroxy-leucine measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, increases methylation1
Valproic Aciddecreases methylation1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.